Sage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.katrina4384Feb 26, 20220 min readUpdated: Mar 31, 2022
Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease
Comments